TIDMSYNC
RNS Number : 6466U
Syncona Limited
02 August 2022
Syncona Limited
Result of Annual General Meeting
2 August 2022
At the Annual General Meeting of Syncona Limited (the "Company")
held today, all Resolutions as set out in the 'Notice of the 2022
Annual General Meeting' dated 30 June 2022 sent to shareholders of
the Company (the "Notice") were duly passed.
Resolutions 1 to 12 were proposed as Ordinary Resolutions.
Resolution 13 was proposed as a Special Resolution and Resolution
14 was proposed as an Extraordinary Resolution.
Details of the proxy voting results, which should be read
alongside the Notice, are noted below:
No Resolution For Discretion Against Abstain
(withheld)
Receive and consider
the Annual Audited
Financial Statements
of the Company for
the year ended 31
March 2022, together
with the Reports
of the Directors
1 and Auditors thereon 464,372,350 (0) 189,929 7,875
(99.96%) (0%) (0.04%)
-------------------------- ------------ ----------- ---------- ------------
Re-appointment of
Deloitte LLP (Guernsey
2 Branch) as Auditors 464,325,349 (0) 53,133 191,672
(99.99%) (0%) (0.01%)
-------------------------- ------------ ----------- ---------- ------------
Authorise the Directors
to determine the
remuneration of the
3 Auditors 464,558,338 (0) 9,578 2,238
(99.99%) (0%) (0.01%)
-------------------------- ------------ ----------- ---------- ------------
Re-elect Melanie
4 Gee as a Director 463,062,580 (0) 1,490,199 17,375
(99.68%) (0%) (0.32%)
-------------------------- ------------ ----------- ---------- ------------
Elect Julie Cherrington
5 as a Director 464,536,562 (0) 4,217 29,375
(99.99%) (0%) (0.01%)
-------------------------- ------------ ----------- ---------- ------------
Elect Cristina Csimma
6 as a Director 464,536,562 (0) 4,217 29,375
(99.99%) (0%) (0.01%)
-------------------------- ------------ ----------- ---------- ------------
Re-elect Virginia
7 Holmes as a Director 463,062,580 (0) 1,490,199 17,375
(99.68%) (0%) (0.32%)
-------------------------- ------------ ----------- ---------- ------------
Re-elect Rob Hutchinson
8 as a Director 463,029,675 (0) 1,523,104 17,375
(99.67%) (0%) (0.33%)
-------------------------- ------------ ----------- ---------- ------------
Re-elect Kemal Malik
9 as a Director 463,020,330 (0) 1,523,104 26,720
(99.67%) (0%) (0.33%)
-------------------------- ------------ ----------- ---------- ------------
Re-elect Gian Piero
10 Reverberi as a Director 463,028,580 (0) 1,521,854 19,720
(99.67%) (0%) (0.33%)
-------------------------- ------------ ----------- ---------- ------------
Approve the report
on implementation
of the Remuneration
Policy for Non-Executive
11 Directors 463,065,971 (0) 1,475,563 28,620
(99.68%) (0%) (0.32%)
-------------------------- ------------ ----------- ---------- ------------
Authority to allot
12 and issue shares 464,193,797 (0) 346,067 30,290
(99.93%) (0%) (0.07%)
-------------------------- ------------ ----------- ---------- ------------
Authorise the Company
to purchase its own
13 shares 464,346,845 (0) 211,264 12,045
(99.95%) (0%) (0.05%)
-------------------------- ------------ ----------- ---------- ------------
Disapply pre-emption
14 rights 456,459,320 (0) 8,088,893 21,941
(98.26%) (0%) (1.74%)
-------------------------- ------------ ----------- ---------- ------------
A vote withheld is not a vote in law and has not been counted in
the votes for and against a resolution.
In accordance with the Listing Rule 9.6.2, a copy of all the
resolutions passed other than resolutions concerning ordinary
business have been submitted to the Financial Conduct Authority via
the National Storage Mechanism and will shortly be available for
inspection at
https://data.fca.org.uk/#/nsm/nationalstoragemechanism .
The full text of the resolutions can be found in the Notice,
which is available on the Company's website at
https://www.synconaltd.com/investors/shareholder-information/shareholder-documents/
.
Enquiries
Syncona Limited
Natalie Garland-Collins / Fergus Witt
Tel: +44 (0) 7714 916615
FTI Consulting
Ben Atwell / Julia Bradshaw / Tim Stamper
Tel: +44 (0) 20 3727 1000
Copies of this press release and other corporate information can
be found on the company website at: www.synconaltd.com .
About Syncona:
Syncona's purpose is to invest to extend and enhance human life.
We do this by founding and building a portfolio of global leaders
in life science to deliver transformational treatments to patients
in areas of high unmet need.
Our strategy is to found, build and fund companies around
exceptional science to create a diversified portfolio of 15-20
globally leading healthcare businesses for the benefit of all our
stakeholders. We focus on developing treatments for patients by
working in close partnership with world-class academic founders and
management teams. Our balance sheet underpins our strategy enabling
us to take a long-term view as we look to improve the lives of
patients with no or poor treatment options, build sustainable life
science companies and deliver strong risk-adjusted returns to
shareholders.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
RAGUPUQPRUPPGGP
(END) Dow Jones Newswires
August 02, 2022 07:28 ET (11:28 GMT)
Syncona (LSE:SYNC)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Syncona (LSE:SYNC)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024
